Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 14 studies | 50% ± 21% | |
amacrine cell | 8 studies | 57% ± 22% | |
retinal rod cell | 8 studies | 42% ± 16% | |
retina horizontal cell | 7 studies | 95% ± 4% | |
retinal ganglion cell | 7 studies | 62% ± 22% | |
retinal cone cell | 7 studies | 42% ± 15% | |
glutamatergic neuron | 7 studies | 45% ± 16% | |
Mueller cell | 6 studies | 74% ± 13% | |
retinal bipolar neuron | 5 studies | 43% ± 20% | |
fibroblast | 4 studies | 36% ± 8% | |
OFF-bipolar cell | 4 studies | 44% ± 26% | |
ON-bipolar cell | 4 studies | 59% ± 17% | |
neuron | 3 studies | 23% ± 7% | |
retinal pigment epithelial cell | 3 studies | 46% ± 10% | |
GABAergic amacrine cell | 3 studies | 70% ± 17% | |
glycinergic amacrine cell | 3 studies | 77% ± 15% | |
rod bipolar cell | 3 studies | 33% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 94% | 1605.86 | 2479 / 2642 | 93% | 9.31 | 658 / 705 |
prostate | 98% | 1105.91 | 240 / 245 | 88% | 7.97 | 441 / 502 |
adrenal gland | 99% | 659.52 | 256 / 258 | 61% | 4.64 | 141 / 230 |
uterus | 49% | 393.34 | 83 / 170 | 19% | 0.77 | 86 / 459 |
heart | 63% | 205.61 | 545 / 861 | 0% | 0 | 0 / 0 |
bladder | 57% | 337.95 | 12 / 21 | 6% | 0.23 | 31 / 504 |
breast | 46% | 133.18 | 212 / 459 | 17% | 0.62 | 188 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 62% | 7.53 | 28 / 45 |
lung | 43% | 158.28 | 249 / 578 | 17% | 0.47 | 196 / 1155 |
blood vessel | 59% | 636.65 | 784 / 1335 | 0% | 0 | 0 / 0 |
adipose | 56% | 182.59 | 680 / 1204 | 0% | 0 | 0 / 0 |
thymus | 45% | 93.04 | 291 / 653 | 11% | 0.30 | 64 / 605 |
esophagus | 20% | 45.82 | 296 / 1445 | 10% | 0.36 | 19 / 183 |
ovary | 29% | 83.95 | 52 / 180 | 2% | 0.05 | 8 / 430 |
skin | 19% | 60.29 | 338 / 1809 | 12% | 0.36 | 55 / 472 |
stomach | 21% | 49.55 | 74 / 359 | 8% | 0.12 | 22 / 286 |
intestine | 23% | 49.31 | 221 / 966 | 3% | 0.05 | 15 / 527 |
pancreas | 2% | 3.09 | 6 / 328 | 15% | 0.25 | 26 / 178 |
eye | 0% | 0 | 0 / 0 | 13% | 0.60 | 10 / 80 |
kidney | 8% | 16.36 | 7 / 89 | 4% | 0.26 | 37 / 901 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.10 | 1 / 29 |
liver | 0% | 1.56 | 1 / 226 | 1% | 0.04 | 5 / 406 |
muscle | 0% | 0.49 | 2 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.72 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0007601 | Biological process | visual perception |
GO_0046548 | Biological process | retinal rod cell development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0042462 | Biological process | eye photoreceptor cell development |
GO_0046549 | Biological process | retinal cone cell development |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0048511 | Biological process | rhythmic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0035881 | Biological process | amacrine cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0008502 | Molecular function | melatonin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RORB |
Protein name | RAR related orphan receptor B isoform 1 (RAR-related orphan receptor B) (cDNA, FLJ93970, Homo sapiens RAR-related orphan receptor B (RORB), mRNA) RAR related orphan receptor B isoform 2 Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta) |
Synonyms | hCG_27313 ROR-BETA NR1F2 RZRB |
Description | FUNCTION: Nuclear receptor that binds DNA as a monomer to ROR response elements (RORE) containing a single core motif half-site 5'-AGGTCA-3' preceded by a short A-T-rich sequence. Considered to have intrinsic transcriptional activity, have some natural ligands such as all-trans retinoic acid (ATRA) and other retinoids which act as inverse agonists repressing the transcriptional activity. Required for normal postnatal development of rod and cone photoreceptor cells. Modulates rod photoreceptors differentiation at least by inducing the transcription factor NRL-mediated pathway. In cone photoreceptor cells, regulates transcription of OPN1SW. Involved in the regulation of the period length and stability of the circadian rhythm. May control cytoarchitectural patterning of neocortical neurons during development. May act in a dose-dependent manner to regulate barrel formation upon innervation of layer IV neurons by thalamocortical axons. May play a role in the suppression of osteoblastic differentiation through the inhibition of RUNX2 transcriptional activity (By similarity). .; FUNCTION: Isoform 1 is critical for hindlimb motor control and for the differentiation of amacrine and horizontal cells in the retina. Regulates the expression of PTF1A synergistically with FOXN4 (By similarity). . |
Accessions | Q58EY0 A0A1L4FMK7 ENST00000376896.8 [Q92753-1] Q92753 ENST00000396204.2 [Q92753-2] |